U.S. pharma big copyright scrapped two experimental weight loss pills past year—a at the time-day-to-day capsule, lotiglipron, as a result of elevated liver enzymes and a 2 times-everyday tablet, danuglipron, on account of solid Unintended effects—but CEO Albert Bourla has explained